Table 2.
Author | Gender | Age (yr) | Treatment | Survival |
Gupta et al[10] | M | 45 | None | NA |
Loo et al[8] | F | 71 | Transcranial orbitotomy | 3 mo |
Schwab et al[12] | M | 19 | Anterior orbitotomy with biopsy | 2 wk (moribund state) |
Wakisaka et al[9] | M | 58 | Left frontotemporal craniotomy | 11 mo |
Lubin et al[22] | M | 69 | 3000 cGy in 2 wk | NA |
Zubler et al[5] | M | 64 | 4000 cGy over 8 wk + chemotherapy | 3 mo |
Srinivasan et al[4] | F | 76 | None | NA |
Scolyer et al[23] | M | 77 | None | NA |
Font et al[13] | F | 79 | Palliative RT | 3 yr |
Kim et al[6] | F | 56 | None | 2 mo |
Machado-Netto et al[11] | M | 57 | Megestrol acetate and Gemcitabine | 15 mo |
Hirunwiwatkul et al[7] | F | 74 | NA | 2 mo |
Tranfa et al[14] | M | 85 | Anterior orbitotomy with excisional biopsy | NA |
Phanthumchinda et al[15] | F | 29 | 5400 cGy in 4 wk | NA |
NA: Not available; RT: Radiation therapy; F: Female; M: Male.